Brian W. Loggie

Phone402-717-0092
Emailbrianloggiecreightonedu
Websitehttps://www.creighton.edu/campus-directory/loggie-brian-w

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Brian W. Loggie is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

1 Finished

SURGICALLY DIRECTED HYPERTHEMIC CHEMOTHERAPY
Loggie, B. B. W., Loggie, B. W. & Loggie, B. W.
8/9/95 → 5/31/00
Project: Research project

71 Article
5 Review article
2 Comment/debate
1 Chapter

Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment
the PSOGI, Jan 2021, In: European Journal of Surgical Oncology. 47, 1, p. 11-35 25 p.
Research output: Contribution to journal › Article › peer-review
50 Scopus citations
Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up
PSOGI, Jan 2021, In: European Journal of Surgical Oncology. 47, 1, p. 36-59 24 p.
Research output: Contribution to journal › Article › peer-review

27 Scopus citations
The Delphi and GRADE methodology used in the PSOGI 2018 consensus statement on Pseudomyxoma Peritonei and Peritoneal Mesothelioma
List of PSOGI collaborators, Jan 2021, In: European Journal of Surgical Oncology. 47, 1, p. 4-10 7 p.
Research output: Contribution to journal › Review article › peer-review
12 Scopus citations
Cytoreduction with hyperthermic intra peritoneal and intra thoracic chemotherapy for metastatic Sertoli-Leydig cell tumor of the ovary
Larsen, N. K., Reilly, M. J., Kwon, S., Loggie, B. W. & Balters, M. W., Nov 2020, In: Gynecologic Oncology Reports. 34, 100638.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies
Kuracha, M. R., Thomas, P., Loggie, B. W. & Govindarajan, V., Jun 2017, In: PloS one. 12, 6, e0179510.
Research output: Contribution to journal › Article › peer-review
10 Scopus citations

Brian W. Loggie, MD

Fingerprint

Network

Dive into details

SURGICALLY DIRECTED HYPERTHEMIC CHEMOTHERAPY

Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment

Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up

The Delphi and GRADE methodology used in the PSOGI 2018 consensus statement on Pseudomyxoma Peritonei and Peritoneal Mesothelioma

Cytoreduction with hyperthermic intra peritoneal and intra thoracic chemotherapy for metastatic Sertoli-Leydig cell tumor of the ovary

Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies

Brian W. Loggie, MD

Fingerprint

Network

Projects

SURGICALLY DIRECTED HYPERTHEMIC CHEMOTHERAPY

Research output

Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment

Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up

The Delphi and GRADE methodology used in the PSOGI 2018 consensus statement on Pseudomyxoma Peritonei and Peritoneal Mesothelioma

Cytoreduction with hyperthermic intra peritoneal and intra thoracic chemotherapy for metastatic Sertoli-Leydig cell tumor of the ovary

Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies